Tailored Nanocarriers for the Pulmonary Delivery of Levofloxacin against Pseudomonas aeruginosa: A Comparative Study-Reference-Cited by-同舟云学术

Tailored Nanocarriers for the Pulmonary Delivery of Levofloxacin against Pseudomonas aeruginosa: A Comparative Study

Published:2019-03-22 Issue:5 Volume:16 Page:1906-1916
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Derbali Rabeb Mouna,Aoun Valery,Moussa Ghina,Frei Giorgia,Tehrani Soudeh F.,Del’Orto Juliana Campos,Hildgen Patrice,Roullin V. Gaëlle,Chain Jeanne Leblond^ORCID

Funder

Faculty of Pharmacy, University of Montr?al

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.8b01256

Reference75 articles.

1. The prevalence of cystic fibrosis in the European Union

2. The relative frequency of CFTR mutation classes in European patients with cystic fibrosis

3. Evidence for Periciliary Liquid Layer Depletion, Not Abnormal Ion Composition, in the Pathogenesis of Cystic Fibrosis Airways Disease

4. Clinical applications of pulmonary delivery of antibiotics

5. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation and optimization of niosome encapsulated meropenem for significant antibacterial and anti-biofilm activity against methicillin-resistant Staphylococcus aureus isolates;Heliyon;2024-08

2. Advances in polymeric and non-polymeric nanocarriers for the magnified delivery of levofloxacin against bacterial infection;Journal of Nanoparticle Research;2024-08

3. OX26-cojugated gangliosilated liposomes to improve the post-ischemic therapeutic effect of CDP-choline;Drug Delivery and Translational Research;2024-03-13

4. Excipients for Novel Inhaled Dosage Forms: An Overview;AAPS PharmSciTech;2024-02-14

5. Lipid-Based Nanomedicines for the Treatment of Bacterial Respiratory Infections: Current State and New Perspectives;Nanomedicine;2024-01-25